A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose
Top Cited Papers
Open Access
- 15 August 2008
- journal article
- Published by American Society of Hematology in Blood
- Vol. 112 (4) , 1022-1027
- https://doi.org/10.1182/blood-2008-01-134247
Abstract
Warfarin dosing is correlated with polymorphisms in vitamin K epoxide reductase complex 1 (VKORC1) and the cytochrome P450 2C9 (CYP2C9) genes. RecentKeywords
This publication has 33 references indexed in Scilit:
- Mapping and sequencing of structural variation from eight human genomesNature, 2008
- CYP4F2 genetic variant alters required warfarin doseBlood, 2008
- Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humansNature Genetics, 2008
- Power to Detect Risk Alleles Using Genome-Wide Tag SNP PanelsPLoS Genetics, 2007
- Pharmacogenetics of warfarin: regulatory, scientific, and clinical issuesJournal of Thrombosis and Thrombolysis, 2007
- Imputation-Based Analysis of Association Studies: Candidate Regions and Quantitative TraitsPLoS Genetics, 2007
- Identifying the genotype behind the phenotype: a role model found inVKORC1and its association with warfarin dosingPharmacogenomics, 2007
- Evaluation of Genetic Factors for Warfarin Dose PredictionClinical Medicine & Research, 2007
- Global variation in copy number in the human genomeNature, 2006
- Association of warfarin dose with genes involved in its action and metabolismHuman Genetics, 2006